University of Nigeria, Nsukka
Welcome,         Profile    Billing    Logout  
 15 Trials 
34 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ezeanolue, Echezona
ACCESS, NCT06128304: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services

Recruiting
N/A
2436
US, RoW
Core Implementation strategies, Core+ Enhanced Implementation Strategies
University of California, San Diego, University of Nigeria Nsukka
HIV, Cervical Cancer
12/26
08/27
NCT06659900: Community Vital Signs (CVS): an Integrated Community-Based Approach to Identify Undiagnosed Hypertension in Nigeria

Not yet recruiting
N/A
24000
RoW
CORE Plus (+), CORE
Oregon Health and Science University, University of Nigeria Nsukka
Hypertension
06/27
06/27
Manager, Project
MAGNAM, NCT05287191: Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care

Recruiting
3
200
Canada
Magnesium sulfate and then Digoxin, Amiodarone
Sunnybrook Health Sciences Centre, Sunnybrook Research Institute
Atrial Fibrillation New Onset
10/25
04/26
LANTERN, NCT06702878: Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

Recruiting
3
4514
US
nasal antimicrobial photodisinfection therapy
Ondine Biomedical Inc.
Surgical Site Infections, Surgical Wound Infection, Infections, Anti-Infective Agents
07/25
08/25
PEMDA-HN, NCT05814666: Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC

Recruiting
2
81
Europe, US, RoW
Danvatirsen, ISIS 481464, AZD9150, Pembrolizumab, Keytruda
Flamingo Therapeutics NV
HNSCC
05/25
05/26
NCT05714657: Shortened Course Adjuvant Radiotherapy Following TORS

Recruiting
2
104
US
Shortened Course Adjuvant Radiotherapy Following TORS
Abramson Cancer Center at Penn Medicine
HPV-Associated Oropharyngeal Squamous Cell Carcinoma
12/25
04/26
NCT06591819: Hypofractionated WPPT With HDR Boost

Recruiting
2
30
US
Hypofractionated Whole Pelvis Proton Therapy with Brachytherapy Boost
Abramson Cancer Center at Penn Medicine
Prostate Cancer
01/26
12/31
GynWPProton, NCT05758688: PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

Recruiting
2
25
US
Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT)
Abramson Cancer Center at Penn Medicine
Cervical Cancer, Uterine Cancer, Endometrial Cancer
05/26
11/26
TRAK-ER, NCT04985266 / 2020-004022-36: A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer

Recruiting
2
1100
Europe
Palbociclib 125Mg Tab, Fulvestrant injection, Tamoxifen, Letrozole, Exemestane, Anastrozole
Royal Marsden NHS Foundation Trust, Pfizer, AstraZeneca, Institute of Cancer Research, United Kingdom, UNICANCER, Gustave Roussy, Cancer Campus, Grand Paris, Invitae Corporation
ER+ Breast Cancer, HER2-negative Breast Cancer
09/27
09/30
NCT05029401: A Study of Oral Ibogaine in Opioid Withdrawal

Completed
1/2
116
Europe
DMX-1002, Ibogaine Hydrochloride, Placebo, Microcrystalline cellulose
atai Therapeutics, Inc., MAC Clinical Research, ERT: Clinical Trial Technology Solutions, Hammersmith Medicines Research
Opiate Withdrawal Syndrome
01/24
01/24
PROSPER, NCT06244771: A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Recruiting
1/2
403
US
FMC-376
Frontier Medicines Corporation
Advanced Solid Tumors With KRAS G12C Mutations, Solid Tumor, Adult, Unresectable Solid Tumor, Metastatic Solid Tumor, Non Small Cell Lung Cancer, Colorectal Cancer, KRAS G12C, Pancreatic Cancer
10/27
04/28
NCT05450549: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL919 in Healthy Participants

Completed
1
47
Europe
DNL919, Placebo
Denali Therapeutics Inc., Takeda
Healthy Participant
06/23
06/23
NCT03832985: Pediatric Reporting of Adult-Onset Genomic Results

Completed
1
427
US
Receive an adult-onset result, Receive a pediatric-onset result, Control - No Result
Geisinger Clinic, National Human Genome Research Institute (NHGRI)
Hereditary Breast and Ovarian Cancer Syndrome, Lynch Syndrome, Familial Hypercholesterolemia
10/24
10/24
MV371 LAI FiH, NCT06558643: Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants

Recruiting
1
24
Europe
MMV371 LAI, Placebo for MMV371
Medicines for Malaria Venture, Quotient Sciences, The Doctors Laboratory
Malaria,Falciparum
03/25
03/25
NCT06639724: Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer

Recruiting
1
36
US
Fostamatinib in combination with chemotherapy (gemcitabine and nab-paclitaxel)
University of California, San Diego, Rigel Pharmaceuticals
Pancreatic Ductal Adenocarcinoma (PDAC)
06/27
12/28
NCT06586255: Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

Recruiting
1
10
US
Concurrent Immunotherapy and Radiation Therapy
Abramson Cancer Center at Penn Medicine
Urothelial Carcinoma Bladder, Bladder Cancer
04/27
04/27
ENHANCE, NCT05866471: The Study: TaVNS and Psilocybin

Recruiting
1
108
US
Psilocybin, Psilocybine, Psilocibin, Filament Health Psilocybin, PEX010, Transcutaneous auricular Vagus Nerve Stimulation (taVNS), Psychosocial Support Alone, Sham taVNS
University of Wisconsin, Madison, Tiny Blue Dot Foundation
Healthy, Psychedelic Experiences, Vagus Nerve Stimulation
11/27
01/28
NCT06129084: A Study to Compare the Results of FGFR Testing by Either CtDNA Blood Testing or Standard Tumor Tissue Testing

Recruiting
N/A
260
Canada
FGFR Testing
Bernie Eigl, Vancouver Prostate Centre, Lady Davis Institute, Bladder Cancer Canada
Metastatic Bladder Cancer, Metastatic Urothelial Carcinoma
03/25
05/25
Focused-PPC, NCT05280951: An Integrated Postpartum Care, Education, and Support Model for Women in Ghana

Recruiting
N/A
192
RoW
Focused-PPC Care, Usual Care
University of Notre Dame, Savana Signatures, Indiana University School of Medicine
Postpartum Care
01/23
06/23
DIAGNOSE CRDS, NCT06188689: Evaluation of A Clinical Diagnostic Test for CRDS

Recruiting
N/A
400
Europe, Canada, RoW
Pacing
Population Health Research Institute, Canadian Institutes of Health Research (CIHR)
Calcium Release Deficiency Syndrome (CRDS)
12/25
03/26
HBS Ancillary, NCT04794543: Effects of Using E-Cigarettes on Lungs in People With HIV

Completed
N/A
23
US
Pennington Biomedical Research Center, National Institute of General Medical Sciences (NIGMS)
Hiv, Lung Injury
08/23
12/23
CAE-E, NCT04622150: Effectiveness RCT of Customized Adherence Enhancement

Recruiting
N/A
190
US
Customized Adherence Enhancement (CAE), Enhanced Treatment as Usual (eTAU)
Case Western Reserve University, National Institute of Mental Health (NIMH)
Bipolar Disorder
11/25
05/26
TECHWISE, NCT06664944: Technology Exposure and Child Health: Wellness Impact and Social Effects: an Observational Product Registry Study

Recruiting
N/A
1000
US
Aura
Mood, Depression Disorders, Anxiety Disorders, Sleep, Eating Disorders, Physical Activity, Loneliness, Stress
12/25
12/25
CRDS Registry, NCT06508164: International

Recruiting
N/A
500
Canada
Population Health Research Institute, Canadian Institutes of Health Research (CIHR)
Calcium Release Deficiency Syndrome
12/50
12/50
NCT06776406: Head Stabilization in Whole Brain RT

Not yet recruiting
N/A
20
US
Freedom Pursuit Robotic Platform
Abramson Cancer Center at Penn Medicine
Brain Cancer
02/27
02/27
RERUN, NCT06809764: Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC

Not yet recruiting
N/A
150
RoW
No drug
Daiichi Sankyo
Non-small Cell Lung Cancer
02/27
02/27
NCT06659900: Community Vital Signs (CVS): an Integrated Community-Based Approach to Identify Undiagnosed Hypertension in Nigeria

Not yet recruiting
N/A
24000
RoW
CORE Plus (+), CORE
Oregon Health and Science University, University of Nigeria Nsukka
Hypertension
06/27
06/27
IMPACT, NCT04330833: Informational Meetings for Planning and Coordinating Treatment

Active, not recruiting
N/A
110
US
Novel Communication Intervention, Enhanced Usual Care Parent Education
Indiana University, National Cancer Institute (NCI)
End of Life, Communication, Cancer Metastatic
04/25
04/25
ASPIRE-II, NCT06668350: Attitudes and Perceptions Attitudes and Smoking Perceptions in the Real Environment -II

Not yet recruiting
N/A
190
US
Smoking outcomes
University of Oklahoma
Cigarillo Flavor
02/29
06/29
NCT06812117: A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)

Not yet recruiting
N/A
720
RoW
No Drug
Daiichi Sankyo
Diabetic Peripheral Neuropathic Pain
02/26
04/26
Safe-De, NCT05058183: Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer

Recruiting
N/A
400
Europe
ctDNA
Royal Marsden NHS Foundation Trust, Massachusetts General Hospital, Natera, Inc.
Breast Cancer
12/25
12/28
NCT05568264: Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit

Recruiting
N/A
192
US
Physical Therapy intervention
Shirley Ryan AbilityLab, Ann & Robert H Lurie Children's Hospital of Chicago, Northwestern University, Northwestern Medicine, University of Illinois at Chicago
Motor Delay, Premature Birth, Intraventricular Hemorrhage, Hypoxic-Ischemic Encephalopathy, Bronchopulmonary Dysplasia
05/26
12/26
NCT01577251: The Radiation Oncology Registry and Biosample Repository

Recruiting
N/A
8000
US
Abramson Cancer Center at Penn Medicine
Neoplasia
12/30
12/30
Onyeka, Tonia
ACCESS, NCT06128304: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services

Recruiting
N/A
2436
US, RoW
Core Implementation strategies, Core+ Enhanced Implementation Strategies
University of California, San Diego, University of Nigeria Nsukka
HIV, Cervical Cancer
12/26
08/27

Download Options